pentoxifylline has been researched along with Idiopathic Parkinson Disease in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a synthetic derivative of xantine which stimulates adenosine receptors, inhibit phosphodiesterase and increases cyclic monophosphate adenosine." | 1.31 | [Parkinsonism or Parkinson's disease unmasked by pentoxifylline?]. ( Serrano-Dueñas, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Maclagan, LC | 1 |
| Visanji, NP | 1 |
| Cheng, Y | 1 |
| Tadrous, M | 1 |
| Lacoste, AMB | 1 |
| Kalia, LV | 1 |
| Bronskill, SE | 1 |
| Marras, C | 1 |
| Godwin-Austen, RB | 1 |
| Twomey, JA | 1 |
| Hanks, G | 1 |
| Higgins, J | 1 |
| Serrano-Dueñas, M | 1 |
3 other studies available for pentoxifylline and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Artificial Intelligence; Case-Control Studies; Dexame | 2020 |
Oxpentifylline in Parkinson's disease.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle | 1980 |
[Parkinsonism or Parkinson's disease unmasked by pentoxifylline?].
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Park | 2001 |